Palisade Bio (PALI) EPS (Basic) Growth (1y) (2011 - 2026)
Palisade Bio (PALI) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-51.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
186.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-52.19% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-100.01% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Palisade Bio |
391.02 Mn |
261.45 Mn |
- |
89.36% |
| Date | Value |
|---|
| Mar 31, 2026 |
89.36% |
| Dec 31, 2025 |
256.52% |
| Sep 30, 2025 |
83.62% |
| Jun 30, 2025 |
82.53% |
| Mar 31, 2025 |
89.76% |
| Dec 31, 2024 |
81.70% |
| Sep 30, 2024 |
68.56% |
| Jun 30, 2024 |
58.13% |
| Mar 31, 2024 |
43.54% |
| Dec 31, 2023 |
-301.60% |
| Sep 30, 2023 |
-80.00% |
| Jun 30, 2023 |
-37.44% |
| Mar 31, 2023 |
37.27% |
| Dec 31, 2022 |
101.34% |
| Sep 30, 2022 |
-1,076.19% |
| Jun 30, 2022 |
-60.72% |
| Mar 31, 2022 |
-1,540.51% |
| Dec 31, 2021 |
-9,014.38% |
| Sep 30, 2021 |
163.64% |
| Jun 30, 2021 |
-435.82% |
